Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on: December 25,2023

Hodgkin lymphoma survivors show signs of dementia in early adulthood

by Leslie Orr,University of Rochester Medical CenterCredit: Pixabay/CC0 Public DomainIn a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s

Updated on:December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on: December 25,2023

Genetic test could guide use of cancer chemotherapy

by Ellie Cawthera,Imperial College LondonDiscovery ofKRASG12mutation status as potential biomarker of outcome of FTD/TPI treatment in mCRC.a, Dot plot showing the associations

Updated on:December 25,2023

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on: June 01,2024

Study hints at why an aggressive form of brain cancer is hard to treat

by Abbey Bigler,Broad Institute of MIT and HarvardAn illustration representing the cellular states of glioblastoma. Credit: Sébastien PerroudGlioblastoma is an incurable brain cancer that kills

Updated on:June 01,2024

Prescription opioids found to increase the risk of falls, especially in those over 85

by University of New South WalesCredit: cottonbro studio from PexelsA new study led by researchers at the National Drug and Alcohol Research Center (NDARC), UNSW Sydney, has explored the associat

Updated on: March 25,2024

Prescription opioids found to increase the risk of falls, especially in those over 85

by University of New South WalesCredit: cottonbro studio from PexelsA new study led by researchers at the National Drug and Alcohol Research Center (NDARC), UNSW Sydney, has explored the associat

Updated on:March 25,2024

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on: July 17,2024

New Study Uncovers Mechanisms Behind LKB1 Mutation-Driven Resistance to Immunotherapy in Lung Cancer

Updated on:July 17,2024

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on: December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on:December 22,2023

New microfluidic device for cancer detection achieves precise separation of tumor entities

by TranSpreadSchematic illustration of high-throughput, continuous-flow ternary separation of tumor cells and clusters from WBCs in large volumes of pleural or abdominal effusions using our spiral-con

Updated on: April 28,2024

New microfluidic device for cancer detection achieves precise separation of tumor entities

by TranSpreadSchematic illustration of high-throughput, continuous-flow ternary separation of tumor cells and clusters from WBCs in large volumes of pleural or abdominal effusions using our spiral-con

Updated on:April 28,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on: January 25,2024

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

Updated on:January 25,2024

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on: March 20,2024

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on:March 20,2024

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on: March 30,2024

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Updated on:March 30,2024